Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check45 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study objectives and criteria related to the efficacy and safety of roxadustat for end-stage renal disease, while adding new collaborators and a revision update.SummaryDifference18%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.